NCCN WEBINAR: Emerging Strategies In The Upfront Treatment Of Hodkgin Lymphoma (2.22 & 2.26.18)

February 12, 2018
By: Julie Poucher Harbin, Writer, DCI

The National Comprehensive Cancer Network (NCCN) invites members to join Robert Chen, MD, of City of Hope Comprehensive Cancer Center, for this free-of-charge NCCN webinar presentation — Emerging Strategies in the Upfront Treatment of Hodgkin Lymphoma — on February 22 (3:30 to 4:45 p.m.) and February 26 (12:30 to 1:45 p.m.).

TARGET AUDIENCE

This initiative is designed to meet the needs of oncologists, hematologists, nurses, pharmacists, physician assistants, and other health care professionals treating Hodgkin lymphoma (HL) patients.

LEARNING OBJECTIVES

Following this activity, participants should be able to:

  • Describe the need for improved treatment options for newly diagnosed Hodgkin lymphoma (HL) patients.
  • Discuss the upfront use of antibody-drug conjugates combined with standard chemotherapy.
  • Comment on the upfront use of PD-1 immune checkpoint inhibitors.

SUPPORTERS

This activity is supported by an educational grant from Seattle Genetics, Inc.

REGISTER